Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib.
Saved in:
| Title: | Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib. |
|---|---|
| Authors: | Chien KS; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Loghavi S; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., McCue D; Departments of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver NG; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia TM; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Short NJ; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa GC; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Haddad FG; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond DE; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Swaminathan M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bazinet A; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bataller A; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bouligny I; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pierce SA; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: cdinardo@mdanderson.org. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Feb; Vol. 26 (2), pp. e223-e228.e3. Date of Electronic Publication: 2025 Dec 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
